Genovis AB (publ.) Share Price Nasdaq Stockholm
Equities
SE0002485979
Medical Equipment, Supplies & Distribution
Sales 2024 * | 155M 14.15M 1.13B | Sales 2025 * | 238M 21.78M 1.74B | Capitalization | 1.84B 168M 13.37B |
---|---|---|---|---|---|
Net income 2024 * | 37M 3.38M 269M | Net income 2025 * | 37M 3.38M 269M | EV / Sales 2024 * | 11.1 x |
Net cash position 2024 * | 120M 10.96M 873M | Net cash position 2025 * | 93M 8.5M 677M | EV / Sales 2025 * | 7.32 x |
P/E ratio 2024 * |
48.9
x | P/E ratio 2025 * |
21.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.42% |
Managers | Title | Age | Since |
---|---|---|---|
Fredrik Olsson
CEO | Chief Executive Officer | 53 | 31/12/01 |
Magnus Långberg
DFI | Director of Finance/CFO | 53 | 31/12/21 |
Rolf Lood
CTO | Chief Tech/Sci/R&D Officer | 40 | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 04/05/20 | |
Director/Board Member | 63 | 31/12/18 | |
Mikael Lönn
BRD | Director/Board Member | 75 | 31/12/13 |
1st Jan change | Capi. | |
---|---|---|
+1.69% | 12.8B | |
-7.57% | 7.61B | |
+3.22% | 5.41B | |
+0.93% | 4.51B | |
+8.48% | 4.49B | |
+9.21% | 2.73B | |
-13.87% | 2.02B | |
-11.63% | 1.73B | |
+3.45% | 1.64B |